IUPAC/Chemical Name
(Z)-5-(5-[(3-[4-Bromophenyl]-2-imino-4-oxothiazolidin-5-ylidene)methyl]furan-2-yl)isoindoline-1,3-dione
InChi Key
ULBOWKXOFOTCMU-NLDKGBHCSA-N
InChi Code
InChI=1S/C22H12BrN3O4S/c23-12-2-4-13(5-3-12)26-21(29)18(31-22(26)24)10-14-6-8-17(30-14)11-1-7-15-16(9-11)20(28)25-19(15)27/h1-10,24H,(H,25,27,28)/b18-10-,24-22?
SMILES Code
O=C1NC(C2=C1C=CC(C3=CC=C(/C=C(SC(N4C5=CC=C(Br)C=C5)=N)/C4=O)O3)=C2)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
494.32
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Alfhili MA, Basudan AM, Aljaser FS, Dera A, Alsughayyir J. Bioymifi, a novel mimetic of TNF-related apoptosis-induced ligand (TRAIL), stimulates eryptosis. Med Oncol. 2021 Oct 11;38(12):138. doi: 10.1007/s12032-021-01589-5. PMID: 34633592.
2: Altun A, Şahin İnan ZD, Yulak F. Death receptor-dependent apoptosis and cell cycle delay induced by bioymifi in human cervical cancer cells. Pak J Pharm Sci. 2022 Jul;35(4):1031-1036. PMID: 36008899.
3: Bai Y, Lam HC, Lei X. Dissecting Programmed Cell Death with Small Molecules. Acc Chem Res. 2020 May 19;53(5):1034-1045. doi: 10.1021/acs.accounts.9b00600. Epub 2020 Apr 16. PMID: 32297735.
4: Tanner MA, Grisanti LA. A Dual Role for Death Receptor 5 in Regulating Cardiac Fibroblast Function. Front Cardiovasc Med. 2021 Aug 30;8:699102. doi: 10.3389/fcvm.2021.699102. PMID: 34527710; PMCID: PMC8437145.
5: Wang G, Wang X, Yu H, Wei S, Williams N, Holmes DL, Halfmann R, Naidoo J, Wang L, Li L, Chen S, Harran P, Lei X, Wang X. Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat Chem Biol. 2013 Feb;9(2):84-9. doi: 10.1038/nchembio.1153. Epub 2012 Dec 23. PMID: 23292651.
6: Tanner MA, Thomas TP, Grisanti LA. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation. J Mol Cell Cardiol. 2019 Nov;136:1-14. doi: 10.1016/j.yjmcc.2019.08.011. Epub 2019 Aug 29. PMID: 31473246.
